Relative Value Partners Group, LLC Viatris Inc Transaction History

Relative Value Partners Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $27,452 - $36,583	-2,984 Reduced 20.92%	11,282 $108,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $26,299 - $34,864	3,016 Added 26.81%	14,266 $158,000
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $18,783 - $24,652	-2,215 Reduced 16.45%	11,250 $96,000
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $133,976 - $165,215	13,465 New	13,465 $131,000

1,091

966M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Relative Value Partners Group, LLC with notifications on news.